| Names | |
|---|---|
| Preferred IUPAC name | Ethyl 2,2-difluoroacetate |
| Other names | Ethyl 2,2-difluoroacetate Ethyl difluoroethanoate Difluoroacetic acid ethyl ester |
| Pronunciation | /ˈiːθɪl daɪˌflʊəroʊəˈsiːteɪt/ |
| Identifiers | |
| CAS Number | 454-31-9 |
| Beilstein Reference | 1721430 |
| ChEBI | CHEBI:131303 |
| ChEMBL | CHEMBL3580601 |
| ChemSpider | 69127 |
| DrugBank | DB14174 |
| ECHA InfoCard | 03e9c1a9-4ffd-4f1f-ae5f-c23d01af0fd8 |
| EC Number | 204-856-4 |
| Gmelin Reference | Gmelin Reference: **79772** |
| KEGG | C19308 |
| MeSH | D017367 |
| PubChem CID | 77652 |
| RTECS number | KL2975000 |
| UNII | 0X68LM5K3D |
| UN number | UN3272 |
| CompTox Dashboard (EPA) | DTXSID4022667 |
| Properties | |
| Chemical formula | C4H6F2O2 |
| Molar mass | 120.08 g/mol |
| Appearance | Colorless transparent liquid |
| Odor | Sweet, fruity |
| Density | 1.238 g/mL at 25 °C (lit.) |
| Solubility in water | slightly soluble |
| log P | 0.64 |
| Vapor pressure | 7.4 hPa (20 °C) |
| Acidity (pKa) | pKa ≈ 1.06 |
| Basicity (pKb) | 15.02 |
| Magnetic susceptibility (χ) | -45.73e-6 cm³/mol |
| Refractive index (nD) | 1.322 |
| Viscosity | 0.685 cP (25°C) |
| Dipole moment | 2.09 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Ethyl Difluoroacetate: 329.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -678.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1032.7 kJ·mol⁻¹ |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation, may cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS02,GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P261, P271, P280, P305+P351+P338, P304+P340, P312, P337+P313 |
| NFPA 704 (fire diamond) | 1-2-0 |
| Flash point | 60 °C |
| Autoignition temperature | 415 °C |
| Lethal dose or concentration | LD50 oral rat 2820 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50 = 3400 mg/kg |
| NIOSH | EWG |
| PEL (Permissible) | Not established |
| REL (Recommended) | 300 mg/kg |
| Related compounds | |
| Related compounds | Methyl Difluoroacetate Difluoroacetic acid Ethyl Fluoroacetate Ethyl Trifluoroacetate Ethyl Acetate |
| Item | Detail / Manufacturer Commentary |
|---|---|
| Product Name | Ethyl Difluoroacetate |
| IUPAC Name | Ethyl 2,2-difluoroacetate |
| Chemical Formula | C4H6F2O2 |
| CAS Registry Number | 454-31-9 |
| Synonyms & Trade Names | 2,2-Difluoroacetic acid ethyl ester; DFAE |
| HS Code & Customs Classification |
HS Code: 2915.90 For international shipments, our export paperwork references the HS group for saturated acyclic monocarboxylic acid esters. Final code selection reflects the nature of the fluoro group substitution and destination customs requirements. |
Ethyl Difluoroacetate’s identification and documentation always start from accurate raw material traceability and process control. Each region and client may require detailed purity, packaging, and grade documentation, so nomenclature must match the actual composition achieved in that batch—especially when trade names are used. Location of synthesis, used starting acid, and esterification pathway can introduce trace differences in impurity profiles, such as presence of unreacted difluoroacetic acid or higher-boiling side-products in some cases.
Customs classification demands understanding of how regulators interpret functional groups. Most jurisdictions classify this under HS 2915.90, but special regulatory scrutiny arises for destinations with enhanced controls on organofluorine intermediates. The manufacturer must align all product paperwork with entered declarations to maintain legal shipment and downstream compliance, particularly when the batch specification covers non-standard esters, isomeric forms, or purposely varied difluoro content for custom applications.
For our dispatched lots, supporting documentation never relies on generalized trade descriptions but references actual, tested material identity. Documentation has to account for physical batch-to-batch realities—naming discrepancies or ambiguous customs codes have previously caused delays or reclassification, so all product labels, SDS, and transportation labels are standardized against real batch records and verified against harmonized tariff schedules prior to shipment.
Ethyl difluoroacetate is typically received as a clear, colorless to pale yellow liquid, with a characteristically sharp, ether-like odor. The melting point and boiling point are process-dependent, with typical production lots showing consistent thermal behavior within expected ranges for esters of similar molecular weight. Density values can vary with temperature; QC monitoring uses in-line densitometers calibrated per batch. Operators notice frequent changes in viscosity and surface tension when exposed to open air, which impacts transfer and filling procedures. These features are directly tied to grade and solvent purity: higher water or alcohol contamination, for instance, can darken hue and impact olfactory signature.
During manufacturing and storage, the compound shows limited hydrolytic stability, especially under alkaline or acidic residues. Excess moisture tends to accelerate hydrolysis to difluoroacetic acid and ethanol. Higher temperature or light exposure can promote ester cleavage and, in rare cases, discoloration or odor formation. Reactivity with strong nucleophiles and bases in the plant setting has prompted the installation of controlled environment enclosures for process-critical steps.
Solubility in organic solvents depends on grade and residual water; GC trace moisture control is essential in downstream use. The standard production route yields a product miscible with a wide range of polar and non-polar solvents under ambient conditions. For customers preparing stock solutions, filtration may be specified to prevent particulate introduction if trace by-products from synthesis remain above threshold.
| Parameter | Industrial Grade | High Purity Grade |
|---|---|---|
| Purity (GC) | Typical values meet downstream requirements | Defined per customer needs |
| Water Content | Controlled by in-process drying | Tighter limits for specialty use |
| Acidity | Monitored by titration | Narrower ranges for electronics/pharma |
| Color (APHA) | Process-variable | Adjusted through polishing if specified |
| Odor | Batch-dependent | Customer specification |
Principal impurities arise from incomplete esterification, raw material carryover, and side-chain cleavage. Each batch sample is tested against upper specification limits derived from internal production averages or, where required, from contract-referenced customer targets. Trace halogenated by-products and unreacted precursors typically form the majority of profile-related concerns in both bulk and pharma-intermediate lots.
Purity and impurities are determined by gas chromatography with internal reference standards. Karl Fischer titration establishes water content. Acidity is checked by potentiometric titration, in some plants cross-validated with infrared spectroscopy. All methods reference validated internal SOPs or, where contractually required, published regional or customer methods.
Ethyl difluoroacetate production relies on difluoroacetic acid (DFA) and ethanol of defined specification. Raw material selection focuses on minimizing halide and water content. Suppliers are qualified by audit and pre-shipment testing. Lateral integration with upstream DFA producers supports both price stability and impurity traceability, a concern for pharmaceutical and agrochemical customers.
Commercial synthesis employs esterification of DFA with ethanol in the presence of an acid catalyst. Batch or continuous processes are selected based on output requirements. Catalyst choice—typically strong mineral acids or organic sulfonates—directly impacts yield, side-product formation, and post-reaction work-up. Higher selectivity processes run at lower temperatures, but production scale favors throughput, leading to a balancing act between cycle time, conversion rates, and purification load.
Key control points include water removal (azeotropic distillation or molecular sieves) and real-time pH adjustment. Process optimization efforts focus on pushing conversions above threshold to limit downstream distillation load. Post-synthesis, the mixture is stripped of low boilers and polished by fractional distillation. Residual acidity, color, and trace alcohol are monitored at splitter and finished product tanks. Critical control charts trigger corrective action when trending out of specification. Customers in regulated segments demand final QC confirmation for every lot; broader industrial users typically review cumulative batch data.
QA labs approve release based on all-process compliance and according to predefined customer or company standards. Out-of-trend results initiate root cause reviews. Full traceability of batch history is mandatory for pharma and food applications. Final release standards are set against both internal criteria and specific end-user requirements, reflecting ongoing dialogue with large-volume accounts.
As an activated fluoroester, ethyl difluoroacetate undergoes nucleophilic substitution and transesterification. High reactivity towards amines and alcohols is noted. Industrial installations frequently generate amides or substituted esters from the base compound for downstream agrochemicals and specialty pharmaceuticals.
Most downstream conversions favor mild to moderate heating under inert conditions. Catalysts are chosen to balance conversion efficiency with by-product control, particularly where highly sensitive applications (e.g., electronic-grade intermediates) drive demand for minimal contamination. Solvent selection is process-specific, ranging from polar aprotic to non-polar solvents depending on the nucleophile type and final use.
Ethyl difluoroacetate serves as a key intermediate for pesticide actives, pharmaceutical ingredients, and specialty polymers. Derivative formation must account for the high leaving potential of the ethoxy group and the electron-withdrawing effect of the difluoroacetyl moiety. The structure enables a range of C–C, C–N, and C–O bond formations en route to more complex molecules.
Producers mandate storage in cool, well-ventilated, and dry locations. Avoidance of direct sunlight and elevated temperature minimizes risk of decomposition and off-odor formation. Humidity control is crucial, as extended moisture exposure increases hydrolysis risk.
Storage vessels must exhibit resistance to fluorinated organic compounds; lined drums or coated stainless steel tanks are standard. Copper and soft metal connections cause stability issues over time and are avoided in tank farms. Bulk handlers visually inspect for corrosion or discoloration before charge-in.
Shelf life is grade- and storage-dependent. QC flags increases in color APHA, acid value, or a sharp increase in off-odors as indicators of degradation. Customer requirements may specify shelf life, validated by periodic stability studies under accelerated and real-time conditions.
Hazard statement assignment follows current regional GHS regulations. Inhalation and skin contact risks require PPE and forced-air ventilation in production and filling areas. Precautionary statements are included on all tank labels and product drums according to the lot’s composition and anticipated use.
Operational experience underlines the need for splash protection during any process transfer, as even dilute solutions can cause local irritation. Trained staff follows written SOPs to minimize exposure. Specific statements reflect observed experience with chemical burns, vapors, and spill response during line maintenance or equipment cleaning.
Industrial hygiene surveys focus on airborne monitoring at major transfer points and packaging stations. Short-term exposure guidelines are referenced from peer-reviewed literature and in-house testing; case-by-case assessments factor in batch-specific impurity levels. Staff rotation and continuous atmospheric sampling further reduce chronic exposure risk. Handling guidelines are updated based on observed incidents and root cause analyses after any deviation from standard practice.
Ethyl difluoroacetate production scales according to ongoing demand in pharmaceuticals, agrochemicals, and specialty intermediates. Production capacity hinges on both the reliability of the difluoroacetic acid supply chain and equipment utilization for esterification. Capacity allocation often responds directly to term contracts and confirmed forecasts from industry customers, especially for high-purity and low-moisture grades. Uncertainty in seasonal feedstock logistics can translate into occasional output restrictions. Bulk production lines are scheduled weekly; limited-grade campaigns run on separate schedules based on campaign batch release. Lead times reflect not just available stock but also mandatory quality release testing.
Standard industrial grades ship within three to five weeks post-purchase order, barring raw material interruptions. Custom grades, including ultra-high and electronics purities, require additional lead time for analytical verification and compliance documentation, often extending to eight weeks or more. The minimum order depends both on packing line format and downstream handling restrictions. Drum and IBC-based volumes typically form the MOQ in international trade, matching batch production efficiency and minimizing contamination or repacking risks.
Packaging choices correlate with both regulatory transport requirements and downstream usage environment. Standard packaging spans from high-density polyethylene drums to passivated steel containers for moisture-sensitive product grades. Low-permeability liners or sealed steel ensure volatility control and prevent hydrolysis, which is more pronounced in higher-purity and electronics-use batches. Specialist grades utilizing custom certifications require validated filling and closure according to customer-specific protocols.
Shipping terms reflect global distribution needs. Hazmat-compliant labelling is standard, as are full container load and LCL shipments depending on trade lanes. Selection between sea and air freight depends on shelf-life sensitivity, batch reservation timelines, and delivery urgency. Payment schedules are structured on a per-account basis, often demanding pre-shipment balance for new customers, while contracted buyers may access deferred terms based on creditworthiness and procurement forecast alignment.
Raw material contributions form a large part of the final cost, majorly difluoroacetic acid and ethanol. Synthetic routes for difluoroacetic acid rely on fluorination intermediates, subject to geopolitical and pollution-control cycles. Feedstock costs can rise if regulatory controls increase or supply tightens in upstream fluorine chemistry. Energy and labor inputs impact overall cost structure most when operational load factors change, especially during scheduled downtimes or mandatory environmental monitoring periods. Exchange rate swings, particularly for feedstocks sourced from outside local currency zones, directly affect quoted prices.
Grade and purity account for most price variance. For electronics or pharmaceutical intermediates, each incremental purity increase necessitates more refined purification—fractional distillation, molecular sieves, or even HPLC fractionation in rare cases. Impurity threshold compliance (e.g., halide or trace acid residues) determines eligibility for regulated applications but requires costly in-process testing and slower batch turnover. Packaging raises the price floor for highly certified grades due to secondary containment and validated closure protocols; labor and analytical documentation add cost tiers, especially for exports requiring full transportation and certification audits.
Ethyl difluoroacetate of industrial and technical grades finds main demand in the US, Europe, China, and increasingly India. US and EU primarily pull for pharmaceutical use, while China drives base demand for agrochemical and fine chemical intermediates. Japan’s market responds heavily to purity improvements, pushing up local procurement costs during qualification runs. Fluctuations in cross-border transport influence landed cost volatility in regions with regulatory import controls or customs delay risks.
US buyers tend to contract for multi-month supply, linking delivered price tightly to reference feedstock indexation and negotiated escalation clauses. EU markets show recurring peaks following regulatory phase-outs of alternative reagents, enhancing demand during transition periods. Japanese purchasing channels expect enhanced batch-to-batch certificate consistency, often dictating small-lot splitting and premium for reformulation testing. Indian buyers prioritize cost-effectiveness for volume synthesis, but packaging and shelf-life differentiation still introduce segmented pricing.
Forecasting considers base case feedstock price outlook, historical contract uplift, and typical regulatory cost pass-through. Based on market analyst data and internal cost models, floor prices in 2026 are expected to reflect modest inflation from energy and environmental compliance expenses, barring abrupt disruptions in key fluorine intermediates. Price peaks can arise quickly if supply chains for regulated grades undergo policy tightening, especially in Asia-Pacific. Bulk technical grade pricing may decouple from pharma and electronics grades due to divergent feedstock sourcing and certification requirements. Methodology references third-party industrial indices, published regulatory updates, and internal quality audit cost accrual models.
Current marketplace adjustments stem from continued tightening of environmental and fluorine-specific waste reduction legislation in China and the EU. These controls periodically affect upstream availability for critical raw materials, cascading into temporary capacity reductions and price uplift for end users.
REACH compliance remains a central factor for exports to the EU, requiring updated substance registrations and periodic revalidation for new critical impurity thresholds. US importers expect regular alignment with TSCA requirements and local fire codes related to flammable intermediates. Ongoing audits now address not only purity but also batch traceability in line with GMP and regional safety protocols.
Mitigation across the supply chain involves diversifying raw material sources, investing in closed-loop purification, and enhancing documentation for regulatory and customer certification processes. Continuous monitoring of impurity profiles and rapid batch requalification support uninterrupted delivery, especially for customers operating under tight production schedules in regulated sectors. Capacity expansion or reservation allocation occurs in step with confirmed contract volumes and signals from regulatory bodies, designed to address cyclic market constraints and ensure supply security.
Ethyl Difluoroacetate functions as a critical intermediate across fine chemical, pharmaceutical, and agrochemical synthesis. In pharmaceuticals, its difluoromethyl group enables the construction of fluorinated active pharmaceutical ingredients, enhancing metabolic stability and bioactivity profiles. Agrochemical producers employ it in the synthesis of difluorinated herbicides and crop protection compounds, particularly for introducing fluorinated motifs that resist biodegradation. Specialty chemical manufacturers also use it in fluorinated polymers and advanced materials as a building block where the presence of difluoromethyl groups impacts final product performance.
| Application Field | Matching Grade | Key Concerns |
|---|---|---|
| API Intermediate Synthesis | Pharma grade | Trace impurities, moisture level, residual solvents |
| Agrochemical Formulation | Technical grade | Purity, specific trace impurity profile |
| Polymer Modification | Industrial grade | Process compatibility, color, odor profile |
Product purity drives downstream yield and impacts trace residue carryover in pharmaceuticals. Pharma grade targets potential process-related impurities using raw material traceability and multi-step purification; this grade responds to customer audits and meets process-specific validation. Moisture control represents another critical parameter in API applications, since hydrolysis of ethyl esters reduces yield and elevates byproduct burdens.
Agrochemical applications emphasize impurity patterns tolerated under regulatory frameworks for crop protection chemicals. Industrial and polymer grades place greater priority on process compatibility and predictable reaction performance rather than on stringent trace control, which would otherwise raise costs without corresponding value for the end use.
Color and odor can differ between grades, as traces of residual starting materials or incomplete purification can cause yellowing or off-odors in batches not intended for high-purity sectors.
Clarify if the end use requires regulatory compliance—for example, pharmaceutical synthesis, crop protection, or general chemical processing. API intermediates and regulated actives demand higher control than performance chemical segments.
Pharmaceutical applications often require compliance with specific regulatory standards for impurity profiles, elemental impurities, and trace solvents. Request documentation supporting quality systems, such as process validation data and impurity tracking. Agrochemical users should specify target crops, country-of-use regulations, and residue tolerances.
Pharma customers frequently require high-purity or ultra-pure grades, controlling for water, nonvolatile content, and preidentified critical impurities. Agrochemical applications can accommodate grades with different impurity matrices as long as regulatory thresholds are respected. Industrial users balance between specification and price, accepting wider tolerances where end-product integrity is not chemically sensitive to minor byproducts.
High-purity and validated batches require additional purification and analytical controls that impact cost and lead time—these are not always necessary for bulk technical applications. For large-volume orders, communicate expected scheduling and anticipate lead time for custom batch adjustments, especially for narrow specification requirements.
Before finalizing supply agreements, request representative samples. Verification by customer analytical labs on actual process compatibility, impurity carryover, and yield impact is standard industrial practice. A sample batch not only verifies grade but also builds confidence in supplier production reproducibility.
Selecting difluoroacetic acid and ethanol sources requires batch-specific traceability, as these raw materials introduce variable impurity profiles. For pharma or critical applications, we reference supplier analytical certification and require declared absence of minor organohalides and heavy metals. Technical and industrial grades implement streamlined input controls to balance cost and process throughput, using broader raw material acceptability windows.
Main process control focuses on complete esterification and minimal hydrolysis back-reaction. Side-reactions such as transesterification or incomplete fluorination generate trace impurities. Batch-to-batch consistency depends on reaction time, catalyst precision, and real-time monitoring of critical quality attributes including moisture, color, and GC-detectable impurities.
Purification intensity differentiates grade. Pharma-grade flows typically integrate multi-stage distillation and adsorption methods, with impurity cut points based on validated analytical methods. Technical and industrial grades rely on efficient one-pass distillation and coarse filtration targeting bulk impurity reduction over exhaustive refinement.
Routine statistical process controls and in-process analytics monitor key properties such as distillation cut profiles, residual water, and target component assay. Release criteria depend on grade and customer specification—pharma and food chain supply orders apply reference samples and retain documentation aligning with ICH or local regulatory standards, while bulk applications operate to tighter scheduling and more pragmatic acceptance criteria.
Moisture uptake and cross-contamination present practical challenges, especially for pharma-grade batches. Closed transfer systems, inert gas blanketing, and container compatibility safeguard sensitive properties and support shelf-life expectations in regulated supply chains. Technical and industrial customers often emphasize simple drum or tote delivery, balancing economics against the need for secure containment and compliance.
Our production of Ethyl Difluoroacetate relies upon an established factory-wide quality management system supported by globally recognized certifications. All major operating units implement documented, auditable controls, with annual third-party re-certification audits. The extent of our quality assurance program, including traceability and batch retention protocols, reflects direct industry and regulatory requirements. For buyers in regulated markets, documented confirmation of our quality system status can be provided upon request, with individual production sites maintaining independent certification validity timelines depending on locale.
Ethyl Difluoroacetate delivered for pharmaceutical or fine chemical synthesis is subject to additional controls specific to both purity and process validation. Certification scope depends on the intended end use: for pharmaceutical precursor applications, impurity profiles and residual solvent limits must align with customer specifications or regional pharmacopeias. For other industrial sectors, certification reporting focuses on elemental analysis, water content, or process-specific attributes—detailing supplied grades, analytical benchmarks, and testing methodologies on file. Final product release criteria are defined by both our internal standards and the individual contractual specification agreed with each customer.
Each batch of Ethyl Difluoroacetate is accompanied by a Certificate of Analysis, referencing analytical protocols traceable to our QA laboratory’s validated methods. Where applicable, change control records, audit documentation, and regulatory support files are available for qualified customers—facilitating due diligence audits and supplier qualification workflows. All retained reports include reference to raw material sources, batch genealogy, and critical production parameters. Access to extended documentation, such as Process Validation Reports or Stability Studies, is managed according to confidentiality agreements and specific customer regulatory filing needs.
Ethyl Difluoroacetate production planning is built around forward order horizons and validated production routes. We manage two independent lines for this molecule, using raw material routes selectively based on supply chain stability, assured by close sourcing partnerships for all key fluorinated intermediates. For high-volume or campaign-based users, allocation agreements and rolling production slots can be established, providing firm delivery schedules and supply buffer inventory where required by critical-path customers.
Core capacity for Ethyl Difluoroacetate is standardized across two process trains and is reserved for contracted customers. Short-term incremental supply adjustments can be implemented if customer requirements shift—subject to process window reconfiguration and precursor availability. Our scale-up approach is based on proven run-history and in-process controls that ensure batch-to-batch consistency. Each new campaign requires an initial scope assessment, integrating both the technical capacity plan and upstream logistical risk mitigation.
Sample quantities for technical evaluation are provided subject to application disclosure and intended use clarification. Requests are managed by our technical service group, with standard sample sizes reflecting both hazard classification and logistics protocols. Customers specifying analytical details or tailored certification needs receive matched sample documentation: we emphasize representative retention sampling, so samples reflect actual bulk production profiles. For customer-specific analytical or down-streaming development, technical consultation is available to align on handling advice, container compatibility, and analytical transfer protocols.
We offer a range of cooperation modes, from spot purchasing for R&D through to annual supply contracts linked to buffer inventory and agile lot release scheduling. Flexible arrangements are based on realistic assessment of production lead times, precursor criticality, and market-driven priority supply. Larger or multi-site customers can consolidate call-off orders, supported by OTA documentation and advance shipping notices aligned to their forecast cycles. For joint process development, our technical teams engage early, coordinating protocols for in-process sample validation and scale transition review. Our business terms are negotiated to balance security of supply with the elasticity that project-based or emergent manufacturing programs may encounter.
Factories and research labs focus much of their work on novel fluorinated intermediates. Ethyl difluoroacetate attracts attention as chemists seek selective difluoroalkylation tools for pharmaceutical and agrochemical synthesis. New synthetic methodologies aim to route this building block into advanced intermediates efficiently, minimizing halogen exchange steps and optimizing yield. Process chemists examine catalyst choices, reagent access, and byproduct minimization for both small- and large-scale campaigns.
Users are increasingly pushing ethyl difluoroacetate into custom derivatives for heterocycle functionalization and selective late-stage functional group installation in drug candidates. As markets for fluorinated medicines and crop protection agents expand, downstream customers demand solutions for constructing metabolically stable and bioactive molecules. Electronics chemical formulators evaluate this ester as a precursor for specialty polymers and as an intermediate in developing low-global-warming-potential refrigerant additives.
Analytical monitoring and purification remain primary hurdles, especially where stringent downstream requirements exist. Process impurity control, especially relating to residual fluoride or acid impurities, receives constant attention. Stability during storage and transport also raises concern; moisture control and inert packaging methods factor into plant logistics. Reactive handling during large-scale synthesis often requires specialized containment to ensure batch-to-batch consistency. Some groups now report more robust catalyst systems and continuous-flow process adaptations, demonstrating improved yield and less off-spec byproduct formation. Process route selection remains heavily influenced by raw material source, local regulatory requirements, and available waste management infrastructure.
Demand for ethyl difluoroacetate correlates with the expansion of fluorinated pharmaceuticals and climate-optimized electronic materials. Growth remains strongest in regions investing in pharmaceutical and agrochemical innovation hubs. Competitive pressure on manufacturing efficiency, impurity profile control, and customizable grade production will likely increase. Fluctuations in raw material costs for fluorinating agents and regulatory trends affecting fluorinated compound manufacturing may impact production planning.
Process developments move toward solvent minimization, alternative energy input, and higher-throughput reactor designs. Automated quality analytics and online monitoring now augment traditional batch-release cycles. Modular facilities allow faster adjustment to market volume shifts or specification changes, especially for highly regulated end uses. Improvements in waste gas capture and on-site reagent recycling support both sustainability goals and cost reduction.
Production increasingly shifts toward milder process conditions and reduced reliance on aggressive halogen sources. Internal teams evaluate bio-based starting materials as replacement candidates where feasible, acknowledging constraints around raw material availability and process compatibility. Closed-loop waste management and emission abatement tend to become standard, especially with growing expectations about environmental impact from international customers. Lifecycle assessment of entire process chains guides both R&D and investment in new plant assets.
Technical support teams draw from production data and application testing to address user questions around process compatibility, impurity risk management, and analytical control. Direct feedback from QC and analytic labs allows real-time troubleshooting of issues such as off-spec reactivity or trace residue detection. Guidance is tailored to customer-specific analytical method setups and formulation targets whenever possible.
Customers often require optimization support as they qualify ethyl difluoroacetate for new syntheses. Specialists advise on solvent system selection, reagent handling, and most compatible reaction conditions for each grade, taking into account the distinct needs of pharmaceutical, agrochemical, or specialty chemical manufacturers. Input from production and QC staff ensures recommendations align with the current manufacturing route and intended application. Stability and storage feedback is grounded in observed batch data and post-shipment follow-up.
Commitment to customers extends from batch traceability and technical query resolution to support during downstream analytical issues. Feedback channels collect field data on application outcomes and allow rapid response to non-conformance. Release criteria are set according to internal QC policy and can be adjusted to align with customer-specific requirements for critical impurities or physical properties. Field support teams engage directly with customer production environments to resolve any observed performance variation, confirming corrective measures at both shipment and plant floor levels.
In-house production of Ethyl Difluoroacetate allows full control over every stage, from raw material handling through synthesis and distillation to finished product filling. Dedicated reactors and proprietary process adjustments give flexibility in capacity and assure lot-to-lot reproducibility. Years of operational data support process optimization for consistent impurity profiles and reliable assay values. No external contract blending or third-party intermediaries handle the product at any step.
Ethyl Difluoroacetate plays a role in organic synthesis for the pharmaceutical and agrochemical sectors. It acts as a key starting material for introducing difluoromethyl groups into specialty intermediates and active compounds. Demand for precision fluorination in medicinal and crop protection chemistry continues to grow, driving increased direct use both in research development and large-scale manufacturing.
Batch records and routine in-process verification underpin rigorous quality control. Analytical techniques—GC, NMR, and titration—monitor each stage, flagging any deviation before final isolation. Finished lots undergo full release testing, not just rapid spot checks. Retained samples from each lot enable traceability in the event of customer queries or regulatory review. Quality management systems align with international industry standards and are subject to scheduled audits.
Ethyl Difluoroacetate leaves production lines in sealed packaging suitable for transit under a controlled supply chain. Standard packaging uses UN-rated drums or cans to address flammability and atmospheric sensitivity. Automated filling equipment, combined with tamper-evident closures and clear batch labeling, eliminates packaging cross-contamination. Supply protocols meet the bulk shipment needs of large-volume buyers and support recurring delivery schedules for repeat production requirements.
Technical staff with process and analytical backgrounds answer application-specific questions from industrial R&D teams and production engineers. On-site resources include applied organic chemists and process safety professionals able to address requirements from scale-up to regulatory submission. Support covers not only product use but also downstream handling, waste management recommendations, and onsite troubleshooting for manufacturing customers.
Direct supply from the manufacturing source gives buyers timelier production feedback and greater flexibility if specification adjustments or urgent orders arise. Procurement teams reduce risk by tapping into a transparent production chain instead of working through opaque third-party channels. Distributors extend reach but retain clean documentation and batch-level traceability. Manufacturers integrating Ethyl Difluoroacetate into end use see tight delivery windows for just-in-time production and streamlined contract management free of extraneous markups.
At our manufacturing facility, Ethyl Difluoroacetate stands out as a go-to building block for synthesis teams searching for robust difluoromethyl sources. Our experience aligns with published research: the molecule's unique balance of electrophilicity and volatility makes it valuable wherever a difluoromethyl group brings performance or selectivity gains.
We see this compound most in medicinal chemistry labs, crop protection R&D, and materials development. Our clients leverage its structure to introduce the -CF2- group into target molecules, a strategy that tends to enhance metabolic stability, generate new molecular geometries, and fine-tune bioactivity. In pharmaceutical research, our product often serves in the construction of difluoromethylated heterocycles or aryl compounds—scaffolds associated with improved pharmacokinetic profiles. The agrochemicals sector favors it for developing innovative pesticide candidates, where fluorine substitution can flip activity spectra or resistance patterns.
Academic and industrial chemists working on specialty polymers and advanced materials also rely on ethyl difluoroacetate to tailor small-molecule monomers. The result: polymers with outstanding thermal or chemical resistance, or new surface properties.
Ethyl Difluoroacetate combines the reactivity of an ester with the electron-withdrawing nature of the difluoromethyl group. In direct practice, this means it works well in ester hydrolysis, nucleophilic substitution, and condensation processes. Its methyl ester function participates reliably in transesterification or saponification reactions. This predictability smooths scale-up from research scale up to pilot lots.
Because the difluoromethyl group pulls electron density, alpha-proton acidity increases versus non-fluorinated analogs. This feature supports enolate formation under controlled conditions—a practical route for C–C bond construction with electrophiles, facilitating aldol-type additions, Michael reactions, and allylation. Researchers favor this adaptability, especially when standard carboxylate esters fail to deliver adequate reactivity or selectivity.
We prioritize strict moisture and impurity controls in our production process to preserve consistent reactivity profiles. This attention to detail matters for those scaling up reactions demanding predictable intermediate behavior. We maintain analytical datasets tracking acid value, purity, and water content batch to batch.
Handling requires due care in storage and transfer. This compound's volatility surpasses some more common esters. We ship in moisture-tight containers and attach sealed ampule options for R&D teams aiming to minimize exposure. Standard packaging typically ranges from lab-sized glass bottles for exploratory projects up to industrial drums for ongoing manufacturing.
For customers developing their own synthetic methods or troubleshooting new routes, our technical team consults on solvent compatibility and reaction work-up based on years of feedback from both academic and industrial partners. We address issues from exothermic transesterification to atmospheric moisture uptake and support process optimization for large-scale needs.
Ethyl difluoroacetate remains a staple in our product line, tailored to the specifics of modern organic synthesis. We commit to technical transparency, comprehensive QC, and hands-on support at every stage. This approach lets innovators—from pharma to advanced materials—work with the confidence that comes from consistent, well-understood performance in every batch.
Manufacturing Ethyl Difluoroacetate takes more than matching a request to what’s on a shelf. From years of chemical synthesis and batch handling in our own facilities, we understand that customers need clear, upfront expectations on order size and delivery pace. We invest in infrastructure and inventory to meet the needs of research labs, pilot plants, and ongoing industrial production cycles.
Ethyl Difluoroacetate production uses specialized fluorination and esterification equipment. We set our minimum order quantity at 25 kilograms per lot for most customers. This batch size aligns with both material handling safety and optimal reactor loading, which means we can ensure consistent quality from start to finish. Offering smaller batch splits increases per-unit costs significantly, does not fit our packaging efficiencies, and raises contamination risks. To avoid unnecessary costs for our partners, we keep MOQ at a level matching plant-scale runs—translating into better cost performance and reliable technical grade product.
We use robust stainless steel or fluoropolymer-lined drums for standard packaging. Each drum comes with tightly-controlled seals and identification, making sure that product integrity holds through transit and storage. For product development or specialty applications, our technical team sometimes evaluates limited smaller lots, but only after a full review of application requirements and plant scheduling.
Lead time comes down to more than just how quickly a batch can be synthesized. For Ethyl Difluoroacetate, raw material sourcing, process queue, and quality release can affect schedule. We maintain backup stocks of key precursors—ethyl alcohol and difluoroacetic acid—that flow straight into continuous processing lines. Under normal production loads, standard lead time averages three weeks from confirmed purchase order to shipment readiness.
For repeat contracts or annual supply agreements, we integrate just-in-time scheduling and inventory reservation, which allow for faster turnaround—sometimes as short as 5 business days out of bonded plant stock. New projects requiring change-of-grade, validation, or specialized QC documentation will see slightly longer preparation. Our technical and logistics teams provide proactive updates throughout synthesis, purification, and final inspection, so customers always have a realistic idea of delivery windows.
Every order of Ethyl Difluoroacetate passes inline analytics for purity and meets all compliance points for hazardous materials handling. We believe in full batch traceability, from precursor supply through distillation to final packaging. Our in-house analytical labs provide supporting COAs and other regulatory documents upon request.
If project ramp-up or scale-down is anticipated, our commercial planners meet directly with purchasing teams to map adjustments to MOQ in line with changing throughput. We’ve found this approach supports our customers’ product development timelines and helps avoid bottlenecks on either side.
Operating as a direct manufacturer means each production run reflects real plant availability and direct material control. We respond quickly to technical inquiries about synthesis pathways, impurities, and storage. Our custom production options accommodate unique purity or volume goals with consultation from our senior chemists. For core orders, our supply assurance starts at the initial engagement and extends through to prompt delivery and after-sales support.
Ethyl Difluoroacetate belongs in the category of functional organofluorine building blocks, commonly used in pharmaceutical R&D, agrochemical synthesis, and specialty chemical applications. Safe, efficient transport sits at the center of our supply chain, and we address this compound’s shipment and import with the direct insight of the manufacturer handling routine international and domestic movements.
Every batch we dispatch is subjected to a rigorous safety review and documentation process, coordinated from our in-house compliance department. Ethyl Difluoroacetate is typically classified as a chemical substance requiring consideration of both physical and health hazards. While our technical assessments show it generally falls outside the most restrictive hazard classes—a relief compared to highly toxic or volatile organics—it displays characteristics that require closed, sealed packaging. We standardize on high-density polyethylene drums and fluoropolymer inner linings for high-volume shipments and glass-lined containers for research quantities, all with tamper-evident closures to prevent leakage and unauthorized access.
From our experience, room temperature storage serves well for Ethyl Difluoroacetate throughout the logistics chain. Our internal QC stability testing at exposure points along different routes confirms it does not require chilling, nor does it demand hot-room avoidance. We focus on exclusion of moisture and aggressive acids or bases during shipment. To minimize possible container degradation during extended transit, our packaging materials undergo compatibility testing for both reactivity and permeability with each production batch.
We routinely field questions about documentary requirements at both customs entry and on the carrier side. Ethyl Difluoroacetate does not appear on precursor or dual-use controlled substance lists issued by primary regulatory authorities such as the US DEA, the European Union, or equivalent Asian agencies. We produce and supply the official Safety Data Sheet (SDS), Certificate of Analysis (COA), and batch-specific production certificates with every order. All documentation matches the nomenclature, CAS number, and regulatory designations accurately. On top of these, we include a Transport Emergency Card and, where applicable, a shipper’s declaration of non-hazardous goods in line with IATA and IMDG protocols. Our logistics staff can provide customs HS codes and tariff information on request to ensure smooth customs clearance.
We enforce responsible chemical stewardship at every stage, from raw material sourcing through to end-user documentation. While Ethyl Difluoroacetate remains unregulated for most chemical commerce, we actively pre-screen new customers linked to sensitive or embargoed regions. Our compliance officers keep up with fast-evolving regulatory regimes to ensure our exports never breach evolving local, national, or multinational controls. We see this as a critical manufacturer’s duty, given the compound’s potential application in life science and material science sectors where dual-use issues can arise unexpectedly.
Strict procedural adherence keeps our shipments reliable and compliant, but supply chains are rarely static. Our regulatory team maintains direct communication with freight forwarders, customs brokers, and regulatory bodies to address changes in transport or import status. We maintain open channels for after-sale support so customers never face uncertainty about documentation or handling, whether moving material cross-border or managing an audit on-site. Ethyl Difluoroacetate, shipped direct from our facility, arrives ready for compliant, safe use.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales9@bouling-chem.com, +8615651039172 or WhatsApp: +8615651039172
